Anti-TRFR/ TRHR/ TRH-R monoclonal antibody

Anti-TRFR/ TRHR/ TRH-R antibody for FACS & in-vivo assay

Target products collectionGo to TRHR/TRHR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T77796-Ab-1/ GM-Tg-hg-T77796-Ab-2Anti-Human TRHR monoclonal antibodyHuman
GM-Tg-rg-T77796-Ab-1/ GM-Tg-rg-T77796-Ab-2Anti-Rat TRHR monoclonal antibodyRat
GM-Tg-mg-T77796-Ab-1/ GM-Tg-mg-T77796-Ab-2Anti-Mouse TRHR monoclonal antibodyMouse
GM-Tg-cynog-T77796-Ab-1/ GM-Tg-cynog-T77796-Ab-2Anti-Cynomolgus/ Rhesus macaque TRHR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T77796-Ab-1/ GM-Tg-felg-T77796-Ab-2Anti-Feline TRHR monoclonal antibodyFeline
GM-Tg-cang-T77796-Ab-1/ GM-Tg-cang-T77796-Ab-2Anti-Canine TRHR monoclonal antibodyCanine
GM-Tg-bovg-T77796-Ab-1/ GM-Tg-bovg-T77796-Ab-2Anti-Bovine TRHR monoclonal antibodyBovine
GM-Tg-equg-T77796-Ab-1/ GM-Tg-equg-T77796-Ab-2Anti-Equine TRHR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T77796-Ab-1/ GM-Tg-hg-T77796-Ab-2; GM-Tg-rg-T77796-Ab-1/ GM-Tg-rg-T77796-Ab-2;
GM-Tg-mg-T77796-Ab-1/ GM-Tg-mg-T77796-Ab-2; GM-Tg-cynog-T77796-Ab-1/ GM-Tg-cynog-T77796-Ab-2;
GM-Tg-felg-T77796-Ab-1/ GM-Tg-felg-T77796-Ab-2; GM-Tg-cang-T77796-Ab-1/ GM-Tg-cang-T77796-Ab-2;
GM-Tg-bovg-T77796-Ab-1/ GM-Tg-bovg-T77796-Ab-2; GM-Tg-equg-T77796-Ab-1/ GM-Tg-equg-T77796-Ab-2
Products NameAnti-TRHR monoclonal antibody
Formatmab
Target NameTRHR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TRHR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TRFR/ TRHR/ TRH-R VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000262human TRHR Lentivirus plasmid
    ORF Viral VectorvGMLP000262human TRHR Lentivirus particle
    ORF Viral VectorpGMLPm003968mouse Trhr Lentivirus plasmid
    ORF Viral VectorvGMLPm003968mouse Trhr Lentivirus particle


    Target information

    Target IDGM-T77796
    Target NameTRHR
    Gene ID7201,22045,25570,698511,482007,101088391,281549,100056618
    Gene Symbol and SynonymsCHNG7,TRH-R,TRH-R1,TRHR
    Uniprot AccessionP34981,Q01717,O46639
    Uniprot Entry NameTRFR_HUMAN,TRHR_RAT,TRHR_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000174417
    Target ClassificationGPCR

    The target: TRHR, gene name: TRHR, also named as TRH-R. This gene encodes a G protein-coupled receptor for thyrotropin-releasing hormone (TRH). Upon binding to TRH, this receptor activates the inositol phospholipid-calcium-protein kinase C transduction pathway. Mutations in this gene have been associated with generalized thyrotropin-releasing hormone resistance. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.